CR Rates, Reasons for Failure, Relapse Risk, and Survival by Hierarchical Cytogenetic Risk Group
| Group . | No. of Patients . | CR (%) . | ID (%) . | RD (%) . | Relapse Risk at 5 yr % (SE) . | Survival at 5 yr % (SE) . |
|---|---|---|---|---|---|---|
| Favorable | 377 | 91* | 8 | 1* | 35 (2.8)* | 65 (2.5)* |
| Intermediate | 1,072 | 86 | 6 | 8 | 51 (1.8) | 41 (1.5) |
| Adverse | 163 | 63 | 14 | 23 | 76 (4.5) | 14 (2.8) |
| Group . | No. of Patients . | CR (%) . | ID (%) . | RD (%) . | Relapse Risk at 5 yr % (SE) . | Survival at 5 yr % (SE) . |
|---|---|---|---|---|---|---|
| Favorable | 377 | 91* | 8 | 1* | 35 (2.8)* | 65 (2.5)* |
| Intermediate | 1,072 | 86 | 6 | 8 | 51 (1.8) | 41 (1.5) |
| Adverse | 163 | 63 | 14 | 23 | 76 (4.5) | 14 (2.8) |
*P < .001, P values are for Mantel-Haenszel (CR and reasons for failure) or log rank (relapse risk and overall survival) test for trend.